About Relay Therapeutics
Relay Therapeutics focuses on drug discovery by studying protein motion to develop new treatments for complex diseases. Their main tool, the Dynamo™ platform, uses both experimental and computational methods to identify potential drug candidates, especially for conditions that are hard to treat with current therapies. This platform allows them to target proteins that have previously been difficult to address, particularly in areas like precision oncology and genetic diseases. Unlike many competitors, Relay Therapeutics emphasizes the importance of protein dynamics in their research, which sets them apart in the biotech field. Their goal is to create effective medicines that can significantly improve patients' lives, and they are actively conducting clinical trials to ensure the safety and effectiveness of their drug candidates.